Monographie - Sotalol hydrochloride - Stabilis 4.0

Posledná aktualizácia :
14/02/2025

beta-blokátor

Sotalol hydrochloride

Perorálny roztok

Stabilita farmaceutických prípravkov

Stabilita v zmesiach

Faktory ovplyvňujúce stabilitu

Kompatibility

Odkazy na literatúru

PDF

Chemický vzorec

Perorálny roztok

Odkazy na literatúru

Perorálny roztok

Odkazy na literatúru : Sotalol hydrochloride

	Typ	Publikácia
2548	Časopis	Nahata MC, Morosco RS. Stability of Sotalol in Two Liquid Formulations at Two Temperatures Ann Pharmacotherapy 2003 ;37:506-509.
2591	Časopis	Dupuis LL, James G, Bacola G. Stability of a sotalol hydrochloride oral liquid formulation. Can J Hosp Pharm 1988 ; 41: 121-123.
3682	Časopis	Klovrzova S, Zahalka L, Kriz T, Zahalkova O, Matysova L, Sklubalova Z, Horak P. Extemporaneous sotalol hydrochloride oral solutions for use in paediatric cardiology: formulation and stability study. EJHP 2016 ;23:33-37
4177	Časopis	Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A. Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4. Int J Pharm Compound 2018 ;22,6:516-526

Mentions Légales